| Literature DB >> 34128977 |
Hai-Bo Yu1, Sheng-Tao Cheng1, Fang Ren1, Yong Chen2, Xiao-Feng Shi3, Vincent Kam Wai Wong4, Betty Yuen Kwan Law4, Ji-Hua Ren1, Shan Zhong5, Wei-Xian Chen6, Hong Mei Xu7, Zhen Zhen Zhang7, Jie Li Hu5, Xue Fei Cai5, Yuan Hu5, Wen Lu Zhang5, Quan-Xin Long3, Lin He5, Zhong Wen Hu5, Hui Jiang5, Hong Zhong Zhou5, Ai-Long Huang1, Juan Chen5.
Abstract
Chronic HBV infection is a significant public health burden worldwide. HBV cccDNA organized as a minichromosome in nucleus is responsible for viral persistence and is the key obstacle for a cure of chronic hepatitis B. Recent studies suggest cccDNA transcription is epigenetically regulated by histone modifications, especially histone acetylation and methylation. In this study, we identified transcriptionally active histone succinylation (H3K122succ) as a new histone modification on cccDNA minichromosome by using cccDNA ChIP-Seq approach. SIRT7, as a NAD+-dependent histone desuccinylase, could bind to cccDNA through interaction with HBV core protein where it catalysed histone H3K122 desuccinylation. Moreover, SIRT7 acts cooperatively with histone methyltransferase SUV39H1 and SETD2 to induce silencing of HBV transcription through modulation of chromatin structure. Our data improved the understanding of histone modifications of the cccDNA minichromosome, thus transcriptional silencing of cccDNA may represent a novel antiviral strategy for the prevention or treatment of HBV infection. Copyright 2021 The Author(s).Entities:
Keywords: Hepatitis B virus; Histone desuccinylase; Histone methylation; Sirtuin 7; cccDNA minichromosome
Year: 2021 PMID: 34128977 DOI: 10.1042/CS20210392
Source DB: PubMed Journal: Clin Sci (Lond) ISSN: 0143-5221 Impact factor: 6.124